Detalles de la búsqueda
1.
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).
Clin Cancer Res
; 28(2): 271-278, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716198
2.
BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer.
Breast Cancer Res Treat
; 113(2): 393-5, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18311584
3.
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.
Clin Genitourin Cancer
; 6(2): 110-6, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18824434
4.
Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancer.
Cancer Med
; 7(7): 2969-2973, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905018
5.
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
JAMA Oncol
; 3(8): 1043-1050, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28208174
6.
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
J Clin Oncol
; 35(35): 3942-3948, 2017 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072977
7.
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
J Clin Oncol
; 31(26): 3197-204, 2013 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23940225
8.
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
J Clin Oncol
; 30(31): 3792-9, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22987084
9.
BRCA1 IVS2-2delA: a deleterious mutation in a family of Asian descent.
Cancer Genet Cytogenet
; 150(2): 173-5, 2004 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15066328
10.
A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer.
Oncologist
; 7(6): 509-15, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12490738
Resultados
1 -
10
de 10
1
Próxima >
>>